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SHORT COMMUNICATION
Tumorigenicity of a combination of psoriasis therapies
D.H. Phillips' & A.J. Alldrick2
'Haddow Laboratories, Institute ofCancer Research, Cotswold Road, Belmont, Sutton, Surrey SM2 SNG, UK; 2British Industrial
Biological Research Association, Woodmansterne Road, Carshalton, Surrey SM5 4DS, UK.
Summary Coal tar, a tumour initiator, and dithranol, a tumour promoter, are used in the treatment of
psoriasis. Topical treatment of mice with pharmaceutical formulations of these two agents, at therapeutic
doses, induced skin papillomas in a classical two-stage carcinogenesis protocol, while treatment with either
agent alone did not. This finding has implications for the use of both agents in combination in the treatment
of psoriasis.
It is estimated that 2-3% of people in Britain suffer from
psoriasis. Many of the remedies for this chronic skin condi-
tion have demonstrable genotoxic effects in experimental
animals and in in vitro assays (Bridges et al., 1981). The
evidence for carcinogenicity in humans of individual
therapies remains, at best, equivocal (Pittelkow et al., 1981;
Wolff, 1990), although excesses of skin cancer have been
observed with combination therapies, for example UV light
and coal tar (Stern et al., 1980).
Coal tar is rich in polycyclic aromatic hydrocarbons, many
of which are potent skin carcinogens and tumour initiators.
Evidence of DNA damage, in the form of aromatic adducts,
has been detected in both mouse and human skin, and also
in mouse internal organs, following topical application of
coal tar (Schoket et al., 1988, 1990). Dithranol (anthralin),
while not carcinogenic in itself, has been shown to act as a
promoter of the growth of tumours initiated by other agents
(Bock & Burns, 1963; Viluksela et al., 1986). Therefore, the
possibility exists that patients previously treated with coal tar
and subsequently using dithranol are being subjected to a
two-stage carcinogenicity protocol akin to the classic mouse
skin model (Berenblum, 1982).
Materials and methods
In order to determine the potential of treatment with coal tar
ointment followed by dithranol to be tumorigenic, the fol-
lowing study was performed. Female CD-1 mice, aged 7-8
weeks, were treated topically five times weekly (Monday to
Friday, inclusive) with 1.5% coal tar ointment (Lorinden)
('initiator', 50 mg per treatment) for 2 weeks, and then with
0.1% dithranol cream ('promoter', 50 mg per treatment)
three times weekly (Monday, Wednesday, Friday) for 40
weeks, beginning I week after finishing coal tar treatment. A
positive control group was initiated with a single treatment
of 50 yg of benzo[a]pyrene (BP) (an initiating, but not com-
pletely carcinogenic, dose; Berenblum, 1982) and then pro-
moted with dithranol. Other groups received either coal tar
or dithranol alone, according to the above protocol. Hair on
the dorsal surface was shaved with electric hair clippers and
material applied to the whole of the shaved area. Mice were
housed individually in grid-bottomed cages. Mice were
examined daily and observations recorded in a day book.
Tumours > 1 mm diameter were scored. The animals were
killed by cervical dislocation and subjected to post-mortem
examination. The skin of the dorsal region was removed and
areas containing lesions were excised. These, together with
organs having an abnormal appearance, were placed in 10%
(v/v) buffered formalin, embedded in paraffin wax, sectioned,
stained with haemotoxylin and eosin and examined micro-
scopically.
In addition, groups of four mice were treated with coal tar
for 2 weeks or benzo[a]pyrene (single dose) as described
above, or untreated, and were killed 9 days after treatment
with BP and 12 days after the final application of coal tar.
Another group was given three doses of dithranol (on alter-
nate days, as described above) and killed 3 days after the
final dose. DNA was isolated from the treated areas of
epidermis, hydrolysed enzymically to nucleoside 3'-mono-
phosphates and then 32P-post-labelled by incubation with T4
polynucleotide kinase and [7_-32P]ATP as previously described
(Phillips et al., 1986; Schoket et al., 1988). The DNA digests
were then subjected to multidirectional thin-layer chromato-
graphy (TLC) on polyethyleneimine (PEI)-cellulose and the
presence of DNA adducts was detected by autoradiography
(Phillips et al., 1986).
Survival plots of time to tumour were calculated using the
Kaplan-Meier method (Kaplan & Meier, 1958). The statis-
tical significance of results was determined by the log-rank
test.
Results and discussion
The chromatograms obtained when digests of DNA from
mouse skin that had been treated with coal tar or BP
confirmed the DNA-binding activity of these agents. In the
case of BP, a single major adduct spot and a number of very
minor ones were detected (Figure lb). With DNA from coal
tar-treated mice, a series of adduct spots in a diagonal band
was observed (Figure la), indicative of DNA binding by a
number of different polycyclic aromatic hydrocarbons, and
similar to adduct patterns induced by similar complex mix-
tures (Schoket et al., 1988, 1990). No adduct spots were
detected in mice that were not treated with an initiator
(Figure lc). The chromatograms of DNA from mice treated
with dithranol were identical to those of DNA from un-
treated mice, confirming that dithranol does not form DNA
adducts in vivo (data not shown). We have previously
reported the absence of DNA adduct formation by dithranol
in human skin treated in organ culture (Schoket et al.,
1990).
The results of the tumorigenicity experiments are shown in
Table I and Figure 2. None of the mice treated with coal tar
or dithranol alone developed tumours during the experiment.
However, four mice (15% of survivors) that had received
coal tar followed by dithranol developed papillomas
(1-2 mm) (significantly different from groups receiving coal
tar or dithranol alone; see Table II), and 12 (44%) had
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Table I Tumorigenicity in mice of psoriasis therapies
Number of Survivors at Mice with Mice with enlarged
Initiator Promoter mice 40 weeksa tumours lymph nodes
Coal tar Dithranol 30 27 4b 12
Benzo[a]pyrene Dithranol 30 28 14c 0
Coal tar None 30 30 0 0
None Dithranol 30 28 0 5
aDeaths of non-tumour-bearing animals occurred at 9, 34 and 35 weeks (coal tar + dithranol); 3 and 27
weeks (BP + dithranol); 19 and 31 weeks (dithranol only). bFirst tumour appeared at 23 weeks. cFirst
tumour appeared at 9 weeks.
Table II Statistical analysis of tumour formation: comparison of
groups treated with initiators and promoters with those treated with
either initiator or promoter. Two-tailed P-values were determined by
the log-rank test
BP + dithranol Coal tar + dithranol
Coal tar only P <0.001 P = 0.036
Dithranol only P <0.001 P = 0.040
Combined groups P <0.001 P = 0.003
Coal tar only and
z dithranol only
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Figure 2 Survival plots of time to appearance of tumours, deter-
mined by Kaplan-Meier method.
Figure 1 Autoradiographs of 32P-post-labelled digests of DNA
chromatographed on PEI-cellulose. a, Skin DNA from mice
treated with 1% coal tar ointment (50 mg, five times weekly,
Monday to Friday, for 2 weeks, animals killed 12 days after final
treatment). b, Skin DNA from mice treated once with BP (50fig)
and killed 9 days later. c, Skin DNA from untreated mice. The
DNA adducts were resolved by multidirectional chromatography
using urea-containing solvents (Phillips et al., 1986). The origins,
located in the lower left corner of each chromatogram, were
excised before autoradiography. Autoradiography was for 2 days
at -75°C.
enlarged cervical lymph nodes. In comparison, 50% of the
surviving mice initiated with benzo[a]pyrene, a potent skin
carcinogen, and promoted with dithranol developed papil-
lomas (1-20 mm); seven mice had more than one tumour.
Five mice that received dithranol only also had enlarged
lymph nodes, while this condition was not observed in any of
the mice treated with coal tar only or with benzo[a]pyrene
followed by dithranol. The papillomas were exophytic with
an irregular thickened epidermis, often covered by a thick
layer of hyperkeratosis. The dermis was infiltrated with
chronic inflammatory cells. In the enlarged lymph nodes, the
normal follicular architecture was present, but there was a
considerable reactive hyperplasia. In some instances, a
moderate to severe sinus histiocytosis was also observed. In
one animal treated with dithranol only, the normal architec-
ture was effaced and replaced with a lymphatic lym-
phoma.
Previous studies have reported the carcinogenicity of long-
term application of coal tar to mouse skin (IARC, 1985), but
the effect of short-term treatment followed by dithranol has
not been previously investigated. The results of the present
pilot study indicate that sequential treatment of mice with
modest therapeutic doses of pharmaceutical formulations
containing coal tar and dithranol is tumorigenic, while
neither agent alone induced tumours at these doses. This
requires further investigation, but suggests that caution
should be exercised when prescribing dithranol therapy to
psoriasis patients who have been treated with coal tar in the
past, as the tumorigenic risk may be magnified by such prior
exposure. In addition, the use of formulations that contain
both coal tar and dithranol (Young & Van Weelden, 1987)
may need to be reviewed.
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